IKKα Cancer Research Results

IKKα, IκB kinase alpha): Click to Expand ⟱
Source:
Type:
Expression of genes involved in nuclear factor (NF)-kappaB activation (NF-κB, IKKα) IKKα (IκB kinase alpha) is a critical component of the NF-κB signaling pathway, which plays a significant role in regulating immune responses, inflammation, and cell survival.
The NF-κB pathway, activated by IKKα, can lead to the production of pro-Inhibitors of the NF-κB pathway, including those targeting IKKα, are being investigated for their potential to treat various cancers.inflammatory cytokines that may create a tumor-promoting microenvironment.


Scientific Papers found: Click to Expand⟱
923- QC,    Quercetin as an innovative therapeutic tool for cancer chemoprevention: Molecular mechanisms and implications in human health
- Review, Var, NA
ROS↑, GSH↓, Ca+2↝, MMP↓, Casp3↑, Casp8↑, Casp9↑, other↓, *ROS↓, *NRF2↑, HO-1↑, TumCCA↑, Inflam↓, STAT3↓, DR5↑, P450↓, MMPs↓, IFN-γ↓, IL6↓, COX2↓, IL8↓, iNOS↓, TNF-α↓, cl‑PARP↑, Apoptosis↑, P53↑, Sp1/3/4↓, survivin↓, TRAILR↑, Casp10↑, DFF45↑, TNFR 1↑, Fas↑, NF-kB↓, IKKα↓, cycD1/CCND1↓, Bcl-2↓, BAX↑, PI3K↓, Akt↓, E-cadherin↓, Vim↓, β-catenin/ZEB1↓, cMyc↓, EMT↓, MMP2↓, NOTCH1↓, MMP7↓, angioG↓, TSP-1↑, CSCs↓, XIAP↓, Snail↓, Slug↓, LEF1↓, P-gp↓, EGFR↓, GSK‐3β↓, mTOR↓, RAGE↓, HSP27↓, VEGF↓, TGF-β↓, COL1↓, COL3A1↓,
3341- QC,    Antioxidant Activities of Quercetin and Its Complexes for Medicinal Application
- Review, Var, NA - Review, Stroke, NA
*antiOx↑, *BioAv↑, *GSH↑, *AChE↓, *BChE↓, *H2O2↓, *lipid-P↓, *SOD↑, *SOD2↑, *Catalase↑, *GPx↑, *neuroP↑, *HO-1↑, *cardioP↑, *MDA↓, *NF-kB↓, *IKKα↓, *ROS↓, *PI3K↑, *Akt↑, *hepatoP↑, P53↑, BAX↑, IGF-1R↓, Akt↓, AR↓, TumCP↓, GSH↑, SOD↑, Catalase↑, lipid-P↓, *TNF-α↓, *Ca+2↓,
5140- SAS,    Suppression of NF-κB activity by sulfasalazine is mediated by direct inhibition of IκB kinases α and β
- in-vitro, AML, Jurkat - in-vitro, CRC, SW-620
TNF-α↓, IKKα↓, NF-kB↓,
3189- SFN,    Sulforaphane Inhibits TNF-α-Induced Adhesion Molecule Expression Through the Rho A/ROCK/NF-κB Signaling Pathway
- in-vitro, Nor, ECV304
*ICAM-1↓, *IL1β↓, *IL6↓, *IL8↓, *p‑IKKα↓, *Rho↓, *ROCK1↓, *ERK↓, *Inflam↓,
1726- SFN,    Sulforaphane: A Broccoli Bioactive Phytocompound with Cancer Preventive Potential
- Review, Var, NA
Dose↝, eff↝, IL1β↓, IL6↓, IL12↓, TNF-α↓, COX2↓, CXCR4↓, MPO↓, HSP70/HSPA5↓, HSP90↓, VCAM-1↓, IKKα↓, NF-kB↓, HO-1↑, Casp3↑, Casp7↑, Casp8↑, Casp9↑, cl‑PARP↑, Cyt‑c↑, Diablo↑, CHOP/DDIT3↑, survivin↓, XIAP↓, p38↑, Fas↑, PUMA↑, VEGF↓, Hif1a↓, Twist↓, Zeb1↓, Vim↓, MMP2↓, MMP9↓, E-cadherin↑, N-cadherin↓, Snail↓, CD44↓, cycD1/CCND1↓, cycA1/CCNA1↓, CycB/CCNB1↓, cycE/CCNE↓, CDK4↓, CDK6↓, p50↓, P53↑, P21↑, GSH↑, SOD↑, GSTs↑, mTOR↓, Akt↓, PI3K↓, β-catenin/ZEB1↓, IGF-1↓, cMyc↓, CSCs↓,
2209- SK,    Shikonin inhibits tumor invasion via down-regulation of NF-κB-mediated MMP-9 expression in human ACC-M cells
- in-vitro, adrenal, ACC-M
MMP9↓, NF-kB↓, IKKα↓,
3042- SK,    The protective effects of Shikonin on lipopolysaccharide/D -galactosamine-induced acute liver injury via inhibiting MAPK and NF-kB and activating Nrf2/HO-1 signaling pathways
- in-vivo, Nor, NA
*TNF-α↓, *IL1β↓, *IL6↓, *IFN-γ↓, *ALAT↓, *AST↓, *MPO↓, *ROS↓, *JNK↓, *ERK↓, *p38↓, *NF-kB↓, *p‑IKKα↓, *SOD↑, *GSH↑, *HO-1↑, *NRF2↑, *hepatoP↑,
1195- SM,    Salvia miltiorrhiza polysaccharide activates T Lymphocytes of cancer patients through activation of TLRs mediated -MAPK and -NF-κB signaling pathways
- in-vitro, Lung, A549 - in-vitro, Liver, HepG2 - in-vitro, CRC, HCT116
T-Cell↑, TumCP∅, IL4↑, IL6↑, IFN-γ↑, TLR4↑, TLR1↑, TLR2↑, p‑JNK↑, p‑ERK↑, IKKα↑,
1817- VitK2,    Research progress on the anticancer effects of vitamin K2
- Review, Var, NA
TumCCA↑, Apoptosis↑, TumAuto↑, TumCI↓, TumCG↓, ChemoSen↓, ChemoSideEff↓, toxicity∅, eff↑, cycD1/CCND1↓, CDK4↓, eff↑, IKKα↓, NF-kB↓, other↑, p27↑, cMyc↓, i-ROS↑, Bcl-2↓, BAX↑, p38↑, MMP↓, Casp9↑, p‑ERK↓, RAS↓, MAPK↓, p‑P53↑, Casp8↑, Casp3↑, cJun↑, MMPs↓, eff↑, eff↑,

Showing Research Papers: 51 to 59 of 59
Prev Page 2 of 2

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 59

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1)

Catalase↑, 1,   GSH↓, 1,   GSH↑, 2,   GSTs↑, 1,   HO-1↑, 2,   lipid-P↓, 1,   MPO↓, 1,   ROS↑, 1,   i-ROS↑, 1,   SOD↑, 2,  

Mitochondria & Bioenergetics(tgid=3)

MMP↓, 2,   XIAP↓, 2,  

Core Metabolism/Glycolysis(tgid=4)

cMyc↓, 3,  

Cell Death(tgid=5)

Akt↓, 3,   Apoptosis↑, 2,   BAX↑, 3,   Bcl-2↓, 2,   Casp10↑, 1,   Casp3↑, 3,   Casp7↑, 1,   Casp8↑, 3,   Casp9↑, 3,   Cyt‑c↑, 1,   Diablo↑, 1,   DR5↑, 1,   Fas↑, 2,   iNOS↓, 1,   p‑JNK↑, 1,   MAPK↓, 1,   p27↑, 1,   p38↑, 2,   PUMA↑, 1,   survivin↓, 2,   TNFR 1↑, 1,   TRAILR↑, 1,  

Kinase & Signal Transduction(tgid=6)

Sp1/3/4↓, 1,  

Transcription & Epigenetics(tgid=7)

cJun↑, 1,   other↓, 1,   other↑, 1,  

Protein Folding & ER Stress(tgid=8)

CHOP/DDIT3↑, 1,   HSP27↓, 1,   HSP70/HSPA5↓, 1,   HSP90↓, 1,  

Autophagy & Lysosomes(tgid=9)

TumAuto↑, 1,  

DNA Damage & Repair(tgid=10)

DFF45↑, 1,   P53↑, 3,   p‑P53↑, 1,   cl‑PARP↑, 2,  

Cell Cycle & Senescence(tgid=11)

CDK4↓, 2,   cycA1/CCNA1↓, 1,   CycB/CCNB1↓, 1,   cycD1/CCND1↓, 3,   cycE/CCNE↓, 1,   P21↑, 1,   TumCCA↑, 2,  

Proliferation, Differentiation & Cell State(tgid=12)

CD44↓, 1,   CSCs↓, 2,   EMT↓, 1,   p‑ERK↓, 1,   p‑ERK↑, 1,   GSK‐3β↓, 1,   IGF-1↓, 1,   IGF-1R↓, 1,   mTOR↓, 2,   NOTCH1↓, 1,   PI3K↓, 2,   RAS↓, 1,   STAT3↓, 1,   TumCG↓, 1,  

Migration(tgid=13)

Ca+2↝, 1,   COL1↓, 1,   COL3A1↓, 1,   E-cadherin↓, 1,   E-cadherin↑, 1,   LEF1↓, 1,   MMP2↓, 2,   MMP7↓, 1,   MMP9↓, 2,   MMPs↓, 2,   N-cadherin↓, 1,   RAGE↓, 1,   Slug↓, 1,   Snail↓, 2,   TGF-β↓, 1,   TSP-1↑, 1,   TumCI↓, 1,   TumCP↓, 1,   TumCP∅, 1,   Twist↓, 1,   VCAM-1↓, 1,   Vim↓, 2,   Zeb1↓, 1,   β-catenin/ZEB1↓, 2,  

Angiogenesis & Vasculature(tgid=14)

angioG↓, 1,   EGFR↓, 1,   Hif1a↓, 1,   VEGF↓, 2,  

Barriers & Transport(tgid=15)

P-gp↓, 1,  

Immune & Inflammatory Signaling(tgid=16)

COX2↓, 2,   CXCR4↓, 1,   IFN-γ↓, 1,   IFN-γ↑, 1,   IKKα↓, 5,   IKKα↑, 1,   IL12↓, 1,   IL1β↓, 1,   IL4↑, 1,   IL6↓, 2,   IL6↑, 1,   IL8↓, 1,   Inflam↓, 1,   NF-kB↓, 5,   p50↓, 1,   T-Cell↑, 1,   TLR1↑, 1,   TLR2↑, 1,   TLR4↑, 1,   TNF-α↓, 3,  

Hormonal & Nuclear Receptors(tgid=20)

AR↓, 1,   CDK6↓, 1,  

Drug Metabolism & Resistance(tgid=21)

ChemoSen↓, 1,   Dose↝, 1,   eff↑, 4,   eff↝, 1,   P450↓, 1,  

Clinical Biomarkers(tgid=22)

AR↓, 1,   EGFR↓, 1,   IL6↓, 2,   IL6↑, 1,   RAGE↓, 1,  

Functional Outcomes(tgid=23)

ChemoSideEff↓, 1,   toxicity∅, 1,  
Total Targets: 132

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1)

antiOx↑, 1,   Catalase↑, 1,   GPx↑, 1,   GSH↑, 2,   H2O2↓, 1,   HO-1↑, 2,   lipid-P↓, 1,   MDA↓, 1,   MPO↓, 1,   NRF2↑, 2,   ROS↓, 3,   SOD↑, 2,   SOD2↑, 1,  

Core Metabolism/Glycolysis(tgid=4)

ALAT↓, 1,  

Cell Death(tgid=5)

Akt↑, 1,   JNK↓, 1,   p38↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12)

ERK↓, 2,   PI3K↑, 1,  

Migration(tgid=13)

Ca+2↓, 1,   Rho↓, 1,   ROCK1↓, 1,  

Immune & Inflammatory Signaling(tgid=16)

ICAM-1↓, 1,   IFN-γ↓, 1,   IKKα↓, 1,   p‑IKKα↓, 2,   IL1β↓, 2,   IL6↓, 2,   IL8↓, 1,   Inflam↓, 1,   NF-kB↓, 2,   TNF-α↓, 2,  

Synaptic & Neurotransmission(tgid=18)

AChE↓, 1,   BChE↓, 1,  

Drug Metabolism & Resistance(tgid=21)

BioAv↑, 1,  

Clinical Biomarkers(tgid=22)

ALAT↓, 1,   AST↓, 1,   IL6↓, 2,  

Functional Outcomes(tgid=23)

cardioP↑, 1,   hepatoP↑, 2,   neuroP↑, 1,  
Total Targets: 41

Scientific Paper Hit Count for: IKKα, IκB kinase alpha)
4 Ashwagandha(Withaferin A)
4 Deguelin
3 Apigenin (mainly Parsley)
3 Baicalein
3 Berbamine
3 Honokiol
3 Nimbolide
3 Sulforaphane (mainly Broccoli)
3 Piperlongumine
3 Quercetin
2 Betulinic acid
2 Curcumin
2 Magnetic Fields
2 Shikonin
1 Alpha-Lipoic-Acid
1 Berberine
1 Boswellia (frankincense)
1 Chlorophyllin
1 Crocetin
1 Diclofenac
1 Emodin
1 Eurycomanone
1 Fenbendazole
1 Fisetin
1 Genistein (soy isoflavone)
1 Ginger/6-Shogaol/Gingerol
1 Luteolin
1 Methyl salicylate / Sweet Birch oil
1 Metformin
1 Magnetic Field Rotating
1 Phenethyl isothiocyanate
1 Piperine
1 Sulfasalazine
1 Salvia miltiorrhiza
1 Vitamin K2
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:156  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page